Double-blind, randomized trial comparing efficacy and safety of continuing olanzapine versus switching to quetiapine in overweight or obese patients with schizophrenia or schizoaffective disorder

Published 2016 View Full Article

Authors

Keywords

Journal

Therapeutics and Clinical Risk Management

Volume Volume 4, Issue -, Pages 713-720

Publisher

Dove Medical Press Ltd.

Online

2016-10-31

DOI

10.2147/tcrm.s3153

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Therapeutics and Clinical Risk Management

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find the ideal target journal for your manuscript

Become a Peeref-certified reviewer